These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A Galactoside-Binding Protein Tricked into Binding Unnatural Pyranose Derivatives: 3-Deoxy-3-Methyl-Gulosides Selectively Inhibit Galectin-1. Pal KB; Mahanti M; Leffler H; Nilsson UJ Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382488 [TBL] [Abstract][Full Text] [Related]
7. Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. Blenda AV; Kamili NA; Wu SC; Abel WF; Ayona D; Gerner-Smidt C; Ho AD; Benian GM; Cummings RD; Arthur CM; Stowell SR J Biol Chem; 2022 Apr; 298(4):101704. PubMed ID: 35148986 [TBL] [Abstract][Full Text] [Related]
8. Structural insights in galectin-1-glycan recognition: Relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties. Porciúncula-González C; Cagnoni AJ; Fontana C; Mariño KV; Saenz-Méndez P; Giacomini C; Irazoqui G Bioorg Med Chem; 2021 Aug; 44():116309. PubMed ID: 34293617 [TBL] [Abstract][Full Text] [Related]
9. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8. Oberg CT; Blanchard H; Leffler H; Nilsson UJ Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029 [TBL] [Abstract][Full Text] [Related]
10. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Carlsson S; Oberg CT; Carlsson MC; Sundin A; Nilsson UJ; Smith D; Cummings RD; Almkvist J; Karlsson A; Leffler H Glycobiology; 2007 Jun; 17(6):663-76. PubMed ID: 17339281 [TBL] [Abstract][Full Text] [Related]
11. Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain. Hassan M; Baussière F; Guzelj S; Sundin AP; Håkansson M; Kovačič R; Leffler H; Tomašič T; Anderluh M; Jakopin Ž; Nilsson UJ ACS Med Chem Lett; 2021 Nov; 12(11):1745-1752. PubMed ID: 34795863 [TBL] [Abstract][Full Text] [Related]
12. Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell function. Sundqvist M; Welin A; Elmwall J; Osla V; Nilsson UJ; Leffler H; Bylund J; Karlsson A J Leukoc Biol; 2018 Feb; 103(2):341-353. PubMed ID: 29345346 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists. Rajput VK; Leffler H; Nilsson UJ; Mukhopadhyay B Bioorg Med Chem Lett; 2014 Aug; 24(15):3516-20. PubMed ID: 24973029 [TBL] [Abstract][Full Text] [Related]
17. Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Yang RY; Hill PN; Hsu DK; Liu FT Biochemistry; 1998 Mar; 37(12):4086-92. PubMed ID: 9521730 [TBL] [Abstract][Full Text] [Related]
18. Investigations on the binding specificity of β-galactoside analogues with human galectin-1 using molecular dynamics simulations. Jino Blessy J; Siva Shanmugam NR; Veluraja K; Michael Gromiha M J Biomol Struct Dyn; 2022; 40(20):10094-10105. PubMed ID: 34219624 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of tricyclic carbohydrate-benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains. Wu C; Yong C; Zhong Q; Wang Z; Nilsson UJ; Zhang Y RSC Adv; 2020 May; 10(33):19636-19642. PubMed ID: 35515421 [TBL] [Abstract][Full Text] [Related]